Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 6 X users

patent: 35 patents

Readers on

mendeley: 81 Mendeley

So far, Altmetric has seen 25 X posts from 6 X users, with an upper bound of 45,228 followers.

RT @sitcancer: New #JITC Research: Enhancing adoptive cancer #immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimul... https:/…

New #JITC Research: Enhancing adoptive cancer #immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimul... https://t.co/2vqVA2Gh1R https://t.co/wdZUs1FIt5

RT @sitcancer: New #JITC Research: Enhancing adoptive cancer #immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimul... https:/…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.